Since 2019, Professor Vladimír Tesař has been a member of the Council of the International Society of Nephrology (ISN), serving as Vice-Chair of the Central and Eastern Europe (CEE) Regional Board. In 2021, he advanced to the ISN Executive Committee and became Chair of the CEE Board. Professor Tesař also contributes to global nephrology guidelines as a member of the KDIGO Board for Glomerulonephritis Guidelines (2021).
Research and Publications
Professor Tesař is a leading researcher in nephrology, with a focus on the diagnosis and treatment of:
- Glomerulonephritides: ANCA-positive vasculitis, lupus nephritis, IgA nephropathy, membranous nephropathy, and focal segmental glomerulosclerosis (FSGS).
- Genetic Kidney Diseases: Including autosomal dominant polycystic kidney disease (ADPKD).
- Renal Conditions: Renovascular hypertension and cardiovascular complications of renal failure.
He has authored or co-authored over 400 peer-reviewed publications indexed on PubMed, with his work appearing in leading journals such as New England Journal of Medicine, The Lancet, JAMA, Annals of Internal Medicine, and Kidney International. With more than 15,000 citations and a Hirsch index of 51, his research has significantly influenced the nephrology field.
Editorial and Academic Leadership
- Editorial Roles:
Professor Tesař serves on the editorial board of Nephrology, Dialysis, Transplantation as a subject editor and contributes to the Clinical Journal of the American Society of Nephrology. - Clinical Trials:
He is a national coordinator and steering committee member for numerous landmark randomized controlled trials, including:- CKD Trials: AURORA, SHARP.
- Diabetic Kidney Disease: SONAR, CCX140.
- IgA Nephropathy: NEPHIGAN, PROTECT, ARTEMIS.
- FSGS: DUET, DUPLEX.
- Membranous Nephropathy and ANCA-Associated Vasculitis: CYCAZAREM, CYCLOPS, IMPROVE, MYCYC, RITUXVAS, CLEAR, PEXIVAS.
Global Impact
Through his clinical and academic work, Professor Tesař has advanced the understanding and treatment of complex kidney diseases, influencing both practice and policy on a global scale.
